Thrombotic events in critically ill children with myocarditis
- PMID: 24016733
- PMCID: PMC3950243
- DOI: 10.1017/S1047951113001145
Thrombotic events in critically ill children with myocarditis
Abstract
Background: Children with myocarditis have multiple risk factors for thrombotic events, yet the role of antithrombotic therapy is unclear in this population. We hypothesised that thrombotic events in critically ill children with myocarditis are common and that children with myocarditis are at higher risk for thrombotic events than children with non-inflammatory dilated cardiomyopathy.
Methods: This is a retrospective chart review of all children presenting to a single centre cardiac intensive care unit with myocarditis from 1995 to 2008. A comparison group of children with dilated cardiomyopathy was also examined. Antithrombotic regimens were recorded. The primary outcome of thrombotic events included intracardiac clots and any thromboembolic events.
Results: Out of 45 cases with myocarditis, 40% were biopsy-proven, 24% viral polymerase chain reaction-supported, and 36% diagnosed based on high clinical suspicion. There were two (4.4%) thrombotic events in the myocarditis group and three (6.7%) in the dilated cardiomyopathy group (p = 1.0). Neither the use of any antiplatelet or anticoagulation therapy, use of intravenous immune globulin, presence of any arrhythmia, nor need for mechanical circulatory support were predictive of thrombotic events in the myocarditis, dilated cardiomyopathy, or combined groups.
Conclusions: Thrombotic events in critically ill children with myocarditis and dilated cardiomyopathy occurred in 6% of the combined cohort. There was no difference in thrombotic events between inflammatory and non-inflammatory cardiomyopathy groups, suggesting that the decision to use antithrombotic prophylaxis should be based on factors other than the underlying aetiology of a child's acute decompensated heart failure.
Conflict of interest statement
R.N. Ichord: Consultant/Advisory Board, Berlin Heart Clinical Event Committee.
Figures
Similar articles
-
Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?Circ Heart Fail. 2016 Jan;9(1):e002328. doi: 10.1161/CIRCHEARTFAILURE.115.002328. Epub 2015 Dec 23. Circ Heart Fail. 2016. PMID: 26699389
-
Short-term outcomes of acute fulminant myocarditis in children.Pediatr Cardiol. 2011 Oct;32(7):885-90. doi: 10.1007/s00246-011-0007-8. Epub 2011 May 17. Pediatr Cardiol. 2011. PMID: 21574064
-
Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression.J Heart Lung Transplant. 1997 Dec;16(12):1248-54. J Heart Lung Transplant. 1997. PMID: 9436137
-
[Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].Med Klin (Munich). 2005 Sep 15;100(9):553-61. doi: 10.1007/s00063-005-1076-3. Med Klin (Munich). 2005. PMID: 16170644 Review. German.
-
Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.Herz. 2004 Sep;29(6):624-36. doi: 10.1007/s00059-004-2628-7. Herz. 2004. PMID: 15912438 Review.
Cited by
-
Coagulation, protease-activated receptors, and viral myocarditis.J Cardiovasc Transl Res. 2014 Mar;7(2):203-11. doi: 10.1007/s12265-013-9515-7. Epub 2013 Nov 8. J Cardiovasc Transl Res. 2014. PMID: 24203054 Free PMC article. Review.
-
Role of a Pediatric Cardiologist in the COVID-19 Pandemic.Pediatr Cardiol. 2021 Jan;42(1):19-35. doi: 10.1007/s00246-020-02476-y. Epub 2020 Oct 4. Pediatr Cardiol. 2021. PMID: 33015722 Free PMC article. Review.
-
SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.J Thromb Haemost. 2021 Feb;19(2):522-530. doi: 10.1111/jth.15216. Epub 2020 Dec 23. J Thromb Haemost. 2021. PMID: 33305475 Free PMC article.
References
-
- Gunthard J, Stocker F, Bolz D, et al. Dilated cardiomyopathy and thrombo-embolism. Eur J Pediatr. 1997;156:3–6. - PubMed
-
- Choi SH, Jeong SI, Yang JH, et al. A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy. Pediatr Cardiol. 2010;31:264–269. - PubMed
-
- Kuhn B, Shapiro ED, Walls TA, Friedman AH. Predictors of outcome of myocarditis. Pediatr Cardiol. 2004;25:379–384. - PubMed
-
- Ramanan AS, Pandit N, Yashwant M, Srinivas A. Embolic stroke in myocarditis. Indian Pediatr. 1993;30:531–533. - PubMed
-
- Antoniak S, Boltzen U, Riad A, et al. Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. J Mol Cell Cardiol. 2008;45:118–126. - PubMed
Publication types
MeSH terms
Grants and funding
- K23 NS062110/NS/NINDS NIH HHS/United States
- K23-NS062110/NS/NINDS NIH HHS/United States
- R01 NS072338/NS/NINDS NIH HHS/United States
- R01-NS072338/NS/NINDS NIH HHS/United States
- T32 NS007413/NS/NINDS NIH HHS/United States
- K23 HL107455/HL/NHLBI NIH HHS/United States
- R01 NS050488/NS/NINDS NIH HHS/United States
- R01-NS050488/NS/NINDS NIH HHS/United States
- K23-HL107455/HL/NHLBI NIH HHS/United States
- K12-NS049453/NS/NINDS NIH HHS/United States
- K12 NS049453/NS/NINDS NIH HHS/United States
- T32-NS007413/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical